 |
Corporate News
22-Aug-23
|
|
|
|
|
|
|
|
|
|
|
|
Piramal Pharma allots 12.96 cr equity shares on rights basis
|
|
|
|
|
|
|
|
Piramal Pharma has allotted 12,96,04,598 equity shares at a price of Rs 81 per equity share (including a premium of Rs 71 per equity share) on rights basis. Accordingly, pursuant to the Allotment, the paid-up equity share capital of the company has increased from Rs 1193,31,85,000 to Rs 1322,92,30,980.
|
|
|
|
Previous News |
Piramal Pharma consolidated net profit rises 350.00% in the September 2024 quarter
(
Results
-
Announcements
24-Oct-24
07:30
)
|
|
|
Piramal Pharma consolidated net profit rises 51.58% in the March 2025 quarter
(
Results
-
Announcements
15-May-25
07:42
)
|
|
|
Piramal Pharma standalone net profit rises 1.53% in the March 2025 quarter
(
Results
-
Announcements
15-May-25
07:41
)
|
|
|
Board of Piramal Pharma recommends final dividend
(
Corporate News
-
15-May-25
10:18
)
|
|
|
Aster DM Healthcare Ltd Surges 9.62%
(
Hot Pursuit
-
24-Oct-24
09:30
)
|
|
|
Piramal Pharma reports standalone net profit of Rs 74.34 crore in the December 2023 quarter
(
Results
-
Announcements
31-Jan-24
07:43
)
|
|
|
Piramal Pharma to table results
(
Corporate News
-
16-Jul-24
10:59
)
|
|
|
Piramal Pharma consolidated net profit rises 102.10% in the March 2024 quarter
(
Results
-
Announcements
11-May-24
07:36
)
|
|
|
Piramal Pharma reports consolidated net profit of Rs 10.11 crore in the December 2023 quarter
(
Results
-
Announcements
31-Jan-24
07:43
)
|
|
|
Board of Piramal Pharma recommends final dividend
(
Corporate News
-
11-May-24
09:40
)
|
|
|
Piramal Pharma to discuss results
(
Corporate News
-
14-Jan-25
14:25
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|